Inovio Clinical Trials: Infectious Disease

Inovio Biomedical or its partners/collaborators are conducting the following ongoing clinical trials for the treatment of infectious diseases. Patients are being recruited for these trials, with details available by following the links below.

Indications: HIV

Treatment: PENNVAX™-B HIV Therapeutic Vaccine (807682)

Study title: A Phase Ib Partially Randomized Pilot Study Intended to Evaluate the Safety and Immunological Effects of HIV-1 DNA Immunization (PENNVAX-B) With or Without Co-Administration of Constructs Containing DNA Encoding for the Expression of Either IL-12 or IL-15 in HIV Infected Individuals

Trial Stage: Phase I

Indications: HIV

Treatment: PENNVAX™-B HIV Preventative Vaccine (HVTN-070)

Study title: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX-B (Gag, Pol, Env) Given Alone, With IL-12 DNA, or With a Dose Escalation of IL-15 DNA, in Healthy, HIV-1-Uninfected Adults Participants

Trial Stage: Phase I (study is ongoing, but not recruiting participants)